HMGIC expression in human adult and fetal tissues and in uterine leiomyomata.
about
HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapyEtiology and pathogenesis of uterine leiomyomas: a reviewLet-7 repression leads to HMGA2 overexpression in uterine leiomyosarcomaDerived variants at six genes explain nearly half of size reduction in dog breedsBinding the mammalian high mobility group protein AT-hook 2 to AT-rich deoxyoligonucleotides: enthalpy-entropy compensation.Sample size calculation for microarray experiments with blocked one-way designMutation analysis of components of the Mediator kinase module in MED12 mutation-negative uterine leiomyomas.Uterine leiomyomata and decreased height: a common HMGA2 predisposition allele.Constitutional rearrangement of the architectural factor HMGA2: a novel human phenotype including overgrowth and lipomas.Disseminated peritoneal leiomyomatosis after laparoscopic supracervical hysterectomy with characteristic molecular cytogenetic findings of uterine leiomyoma.let-7 miRNAs can act through notch to regulate human gliogenesisAggressive angiomyxoma with t(12;21) and HMGA2 rearrangement: report of a case and review of the literatureA novel anti-proliferative role of HMGA2 in induction of apoptosis through caspase 2 in primary human fibroblast cellsExpression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity.Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advancesMolecular deregulation induced by silencing of the high mobility group protein A2 gene in retinoblastoma cells.Heat shock protein 90 is involved in the regulation of HMGA2-driven growth and epithelial-to-mesenchymal transition of colorectal cancer cells.Silencing of High Mobility Group Isoform I-C (HMGI-C) Enhances Paclitaxel Chemosensitivity in Breast Adenocarcinoma Cells (MDA-MB-468)Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction.HMGI-C suppressing induces P53/caspase9 axis to regulate apoptosis in breast adenocarcinoma cells.Association of a high mobility group gene (HMGA2) variant with bone mineral density.Mechanisms of therapeutic resistance in cancer (stem) cells with emphasis on thyroid cancer cells.Advances in serous tubal intraepithelial carcinoma: correlation with high grade serous carcinoma and ovarian carcinogenesis.An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue.Effect of silencing of high mobility group A2 gene on gastric cancer MKN-45 cells.HMGA2 inhibits apoptosis through interaction with ATR-CHK1 signaling complex in human cancer cells.High Mobility Group A2 protects cancer cells against telomere dysfunction.Dovitinib enhances temozolomide efficacy in glioblastoma cells.Cell-based high-throughput compound screening reveals functional interaction between oncofetal HMGA2 and topoisomerase I.Expression levels of HMGA2 in adipocytic tumors correlate with morphologic and cytogenetic subgroups.Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease.Intravenous leiomyomatosis: an unusual intermediate between benign and malignant uterine smooth muscle tumors.
P2860
Q24313419-B56A2291-57A3-4126-9547-C6341AAE7699Q24815132-73F752BF-F168-4AF1-870C-E32B4ABB2A7EQ28251930-72DE2E56-892D-4AAB-A3C2-96BFA22C20FAQ28661364-587659FF-D7A6-4F5C-B719-E975132697DEQ30481431-4FEB79C7-8F40-4D7F-8F18-BA9A6E163F19Q33454978-DC752709-9D10-41D9-AB6D-CCDE01CC3830Q33555242-D8A4800B-D629-4178-A267-74836EF096D4Q33731403-A531675D-5A5A-43C0-A278-EF37587157E6Q33938571-5C3B3AE8-88BE-4C59-B871-8849C7F47E0DQ34200520-4D789BB0-2E87-4AAA-B26E-BC4FC5D0960AQ34530170-0B1E04B3-D050-49B2-A925-C2D0EEDEAADFQ34754450-80B68A66-B529-4456-8698-F453EC6BB884Q34951895-76290B38-8AE6-45FE-B192-7C8F0E21E338Q35909440-DFF2CF71-7421-4363-A7F4-4AF1CE7E14ECQ35944399-4D946AB3-3E36-4B6D-9F82-3E19CD4A42EDQ36198889-3408B7D0-95FC-48B1-8563-73D0A808F30CQ36322333-356DEEC0-D227-4F70-9D49-01B5F838D5E1Q36588726-0EC64B32-E6AE-43D3-80BF-77CF69E96D3CQ37128321-18CA3B5F-49AF-4FFD-8411-A8EFEED99C90Q37218723-DF1BAA37-68F6-4040-9CB5-DE140B32E637Q37317043-5DC26FA2-ACC7-462B-9105-39421418072FQ37482348-6761301C-69FB-422E-BA54-6F1FC7E0C208Q37676466-B0B8D5CB-F216-4AD5-8444-8A23A5CC4D76Q37676705-27B207F4-AA4B-4679-8454-7DFAAB80D2B2Q38303658-B2EEAF8F-34C4-48F6-8279-A9B8690E44A3Q39182057-8BBD682A-87C5-4578-80C1-7DBDB988475DQ39182492-34D2F760-C3C2-45F7-860F-14A83EECDFE6Q40073650-8F63706B-DDC4-4FBD-BE3E-3FD024D5961BQ40214485-8F0A2080-500A-4B06-960A-17D75BDE0D93Q41881025-08F9821E-E865-49FF-AE73-2BD6F608596CQ41934286-CD440F34-DECB-4A77-9F01-1CBA3EA3F870Q47850947-1E795640-EAC0-4489-AE7E-0A7561458836Q52884225-6020BBE6-0BDD-4897-AD0B-FBDC0EC09E54
P2860
HMGIC expression in human adult and fetal tissues and in uterine leiomyomata.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
HMGIC expression in human adult and fetal tissues and in uterine leiomyomata.
@ast
HMGIC expression in human adult and fetal tissues and in uterine leiomyomata.
@en
type
label
HMGIC expression in human adult and fetal tissues and in uterine leiomyomata.
@ast
HMGIC expression in human adult and fetal tissues and in uterine leiomyomata.
@en
prefLabel
HMGIC expression in human adult and fetal tissues and in uterine leiomyomata.
@ast
HMGIC expression in human adult and fetal tissues and in uterine leiomyomata.
@en
P2093
P1476
HMGIC expression in human adult and fetal tissues and in uterine leiomyomata.
@en
P2093
P304
P356
10.1002/(SICI)1098-2264(199908)25:4<316::AID-GCC2>3.3.CO;2-S
P577
1999-08-01T00:00:00Z